Back to Search

PAUL HESKETH, MD

MD

Hematology & Oncology Physician

NPI: 1265427181IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

46159(MA)

CMS Specialties

PrimaryMEDICAL ONCOLOGY

Education

UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE

Class of 1978

Research & Publications (20)

Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.
PMID 19066985·Support Care Cancer·2009
3-trial
Chemotherapy-induced nausea and vomiting.
PMID 18525044·N Engl J Med·2008
6-review
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.
PMID 18758306·J Thorac Oncol·2008
3-trial
Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6.
PMID 17545843·J Thorac Oncol·2007
2-rct
Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.
PMID 17473660·J Thorac Oncol·2007
3-trial
Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027).
PMID 17409914·J Thorac Oncol·2006
3-trial
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
PMID 17409984·J Thorac Oncol·2006
3-trial
Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response.
PMID 16450086·Support Care Cancer·2006
2-rct
Understanding the pathobiology of chemotherapy-induced nausea and vomiting. Providing a basis for therapeutic progress.
PMID 15510975·Oncology (Williston Park)·2004
6-review
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies.
PMID 14770445·Cancer·2004
3-trial
Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches.
PMID 15221580·Support Care Cancer·2004
6-review
New treatment options for chemotherapy-induced nausea and vomiting.
PMID 15232725·Support Care Cancer·2004
6-review
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.
PMID 12736106·Eur J Cancer·2003
4-observational
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.
PMID 14559886·J Clin Oncol·2003
3-trial
Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancer.
PMID 14653876·Clin Lung Cancer·2002
8-other
Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting.
PMID 11497388·Support Care Cancer·2001
6-review
Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting.
PMID 10705879·Cancer Invest·2000
4-observational
Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen.
PMID 10650897·Support Care Cancer·2000
3-trial
Birth and re-birth.
PMID 18663480·Support Care Cancer·2008
8-other
Stress-induced chemical detection using flexible metal-organic frameworks.
PMID 18841964·J Am Chem Soc·2008
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
LAHEY CLINIC, 41 MALL RD
BURLINGTON, MA 01805

Location

Practice Location

LAHEY CLINIC, BURLINGTON, MA
(781) 744-8400

Quick Facts

NPI
1265427181
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
48
Publications
20

Are you this provider?

Claim Your Profile